Atrial fibrillation among African Americans, Hispanics and Caucasians: Clinical features and outcomes from the AFFIRM trial

Journal of the National Medical Association

Volumn 98, Issue 3, 2006, Pages 330-339

  Bush, David ^a   Martin, Lisa W ^b   Leman, Robert ^c   Chandler, Mary ^d   Haywood, L Julian ^e  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Axio Research Corporation   (United States)

^e LAC USC MEDICAL CENTER   (United States)

Author keywords

African Americans; Atrial fibrillation; Caucasians; Ethnicity; Hispanics; Minority

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; FLECAINIDE; MORACIZINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; WARFARIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVERSION; CAUCASIAN; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STROKE; SURVIVAL TIME;

AFRICAN AMERICANS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33644803090     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-2461.
2. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol. 2002;155:819-826.
3. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention; the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147:1561-1564.
5. Gillum RF. The epidemiology of coronary heart disease and stroke in African-American elders. Am J Geriatr Cardiol. 1997;6:21-31.
6. Longstreth WT Jr, Bernick C, Fitzpatrick A, et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology. 2001;56:368-375.
7. Gillum RF. Stroke mortality in blacks. Disturbing trends. Stroke. 1999;30:1711-1715.
8. Kuhlemeier KV, Stiens SA. Racial disparities in severity of cerebrovascular events. Stroke. 1994;25:2126-2131.
9. Age-specific excess deaths associated with stroke among racial/ethnic minority populations-United States, 1997. MMWR. 2000;49:94-97.
10. Gorey KM, Trevisan M. Secular trends in the United States. Black/white hypertension prevalence ratio: potential impact of diminishing response rates. Am J Epidemiol. 1998;147:95-99;discussion 100-102.
11. Gillum RF. Epidemiology of stroke in Hispanic Americans. Stroke. 1995;26:1707-1712.
12. Gillum RF. Risk factors for stroke in blacks: a critical review. Am J Epidemiol. 1999;150:1266-1274.
13. Klag MJ, Whelton K, Coresh J, et al. The association of skin color with blood pressure in U.S. blacks with low socioeconomic status. JAMA. 1991;265:599-602.
14. Bassett DR Jr, Fitzhugh EC, Crespo CJ, et al. Physical activity and ethnic differences in hypertension prevalence in the United States. Prev Med. 2002;34:179-186.
15. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.
16. Bush D, Tayback M. Anticoagulation for nonvalvular atrial fibrillation: effects of type of practice on physicians' self-reported behavior. Am J Med. 1998;104:148-151.
17. The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J. 2002;143:991-1001.
18. The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
19. Upshaw CB Jr. Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study. J Natl Med Assoc. 2002;94:204-208.
20. Haywood J. Atrial fibrillation: an important issue for African Americans? J Natl Med Assoc. 2002;94:264-265.